145 related articles for article (PubMed ID: 37243811)
1. STAT5b gain-of-function disease in a child with mycobacterial osteomyelitis of the skull: rare presentation of an emerging disease entity.
Kobets AJ; Ahmad S; Boyke A; Oriko D; Holland R; Eisenberg R; Alavi SAN; Abbott R
Childs Nerv Syst; 2023 Aug; 39(8):2071-2077. PubMed ID: 37243811
[TBL] [Abstract][Full Text] [Related]
2. STAT5b: A master regulator of key biological pathways.
Smith MR; Satter LRF; Vargas-Hernández A
Front Immunol; 2022; 13():1025373. PubMed ID: 36755813
[TBL] [Abstract][Full Text] [Related]
3. Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation.
Kayaoglu B; Kasap N; Yilmaz NS; Charbonnier LM; Geckin B; Akcay A; Eltan SB; Ozturk G; Ozen A; Karakoc-Aydiner E; Chatila TA; Gursel M; Baris S
J Clin Immunol; 2021 May; 41(4):769-779. PubMed ID: 33475942
[TBL] [Abstract][Full Text] [Related]
4. JAK inhibition in early-onset somatic, nonclonal STAT5B gain-of-function disease.
Eisenberg R; Gans MD; Leahy TR; Gothe F; Perry C; Raffeld M; Xi L; Blackstone S; Ma C; Hambleton S; Milner JD
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):1008-1010.e2. PubMed ID: 33290916
[No Abstract] [Full Text] [Related]
5. A Recurrent
Kieslinger M; Swoboda A; Kramer N; Freund P; Pratscher B; Neubauer HA; Steinborn R; Wolfesberger B; Fuchs-Baumgartinger A; Moriggl R; Burgener IA
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680385
[TBL] [Abstract][Full Text] [Related]
6. Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations-10 Children and Review of the Literature.
Deyà-Martínez A; Rivière JG; Roxo-Junior P; Ramakers J; Bloomfield M; Guisado Hernandez P; Blanco Lobo P; Abu Jamra SR; Esteve-Sole A; Kanderova V; García-García A; Lopez-Corbeto M; Martinez Pomar N; Martín-Nalda A; Alsina L; Neth O; Olbrich P
J Clin Immunol; 2022 Jul; 42(5):1071-1082. PubMed ID: 35486339
[TBL] [Abstract][Full Text] [Related]
7. JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences.
Ott N; Faletti L; Heeg M; Andreani V; Grimbacher B
J Clin Immunol; 2023 Aug; 43(6):1326-1359. PubMed ID: 37140667
[TBL] [Abstract][Full Text] [Related]
8. Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation.
Bloomfield M; Kanderová V; Paračková Z; Vrabcová P; Svatoň M; Froňková E; Fejtková M; Zachová R; Rataj M; Zentsová I; Milota T; Klocperk A; Kalina T; Šedivá A
J Clin Immunol; 2018 Jul; 38(5):589-601. PubMed ID: 29934865
[TBL] [Abstract][Full Text] [Related]
9. JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL.
Wahnschaffe L; Braun T; Timonen S; Giri AK; Schrader A; Wagle P; Almusa H; Johansson P; Bellanger D; López C; Haferlach C; Stern MH; Dürig J; Siebert R; Mustjoki S; Aittokallio T; Herling M
Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31766351
[TBL] [Abstract][Full Text] [Related]
10. Primary epiphyseal osteomyelitis caused by mycobacterium species in otherwise healthy toddlers.
Yoo WJ; Choi IH; Yun YH; Cho TJ; Cheon JE; Song MH; Chung CY; Park MS; Choi E; Lee HJ; Park KU
J Bone Joint Surg Am; 2014 Sep; 96(17):e145. PubMed ID: 25187589
[TBL] [Abstract][Full Text] [Related]
11. Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia.
Cross NCP; Hoade Y; Tapper WJ; Carreno-Tarragona G; Fanelli T; Jawhar M; Naumann N; Pieniak I; Lübke J; Ali S; Bhuller K; Burgstaller S; Cargo C; Cavenagh J; Duncombe AS; Das-Gupta E; Evans P; Forsyth P; George P; Grimley C; Jack F; Munro L; Mehra V; Patel K; Rismani A; Sciuccati G; Thomas-Dewing R; Thornton P; Virchis A; Watt S; Wallis L; Whiteway A; Zegocki K; Bain BJ; Reiter A; Chase A
Leukemia; 2019 Feb; 33(2):415-425. PubMed ID: 30573779
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional consequences of the STAT5B
de Araujo ED; Erdogan F; Neubauer HA; Meneksedag-Erol D; Manaswiyoungkul P; Eram MS; Seo HS; Qadree AK; Israelian J; Orlova A; Suske T; Pham HTT; Boersma A; Tangermann S; Kenner L; Rülicke T; Dong A; Ravichandran M; Brown PJ; Audette GF; Rauscher S; Dhe-Paganon S; Moriggl R; Gunning PT
Nat Commun; 2019 Jun; 10(1):2517. PubMed ID: 31175292
[TBL] [Abstract][Full Text] [Related]
13. STAT5b deficiency: lessons from STAT5b gene mutations.
Hwa V; Nadeau K; Wit JM; Rosenfeld RG
Best Pract Res Clin Endocrinol Metab; 2011 Feb; 25(1):61-75. PubMed ID: 21396575
[TBL] [Abstract][Full Text] [Related]
14. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
Ogawa K; Sano C
Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
[TBL] [Abstract][Full Text] [Related]
15. The Emerging Role of Janus Kinase Inhibitors in the Treatment of Cancer.
Karati D; Mahadik KR; Trivedi P; Kumar D
Curr Cancer Drug Targets; 2022; 22(3):221-233. PubMed ID: 35232350
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of mycobacterium avium osteomyelitis and arthritis in a non-immunocompromised child.
Frosch M; Roth J; Ullrich K; Harms E
Scand J Infect Dis; 2000; 32(3):328-9. PubMed ID: 10879611
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia.
Bhattacharya D; Teramo A; Gasparini VR; Huuhtanen J; Kim D; Theodoropoulos J; Schiavoni G; Barilà G; Vicenzetto C; Calabretto G; Facco M; Kawakami T; Nakazawa H; Falini B; Tiacci E; Ishida F; Semenzato G; Kelkka T; Zambello R; Mustjoki S
Blood Cancer J; 2022 Feb; 12(2):31. PubMed ID: 35210405
[TBL] [Abstract][Full Text] [Related]
18. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
19. Disseminated Mycobacterium avium complex infection in a child with partial dominant interferon gamma receptor 1 deficiency in India.
Sharma VK; Pai G; Deswarte C; Lodha R; Singh S; Kang LW; Yin CC; Casanova JL; Bustamante J; Kabra SK
J Clin Immunol; 2015 Jul; 35(5):459-62. PubMed ID: 26054576
[TBL] [Abstract][Full Text] [Related]
20. A case of hypereosinophilic syndrome with STAT5b N642H mutation.
Ding F; Wu C; Li Y; Mukherjee S; Ghosh S; Arrossi AV; Krishnan S
Oxf Med Case Reports; 2021 Jan; 2021(1):omaa129. PubMed ID: 33542831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
